Literature DB >> 15107636

Resurgence in infectious syphilis in Ireland: an epidemiological study.

S Hopkins1, F Lyons, C Coleman, G Courtney, C Bergin, F Mulcahy.   

Abstract

INTRODUCTION: In 2000, a syphilis outbreak was identified in Ireland.
MATERIALS AND METHODS: A prospective enhanced database was established in 2000. Crude incidence rates for the general population, men who have sex with men (MSM), and HIV-positive MSM were calculated.
RESULTS: Three hundred fifty-six cases of infectious syphilis were diagnosed at 1 center. Eighty-five percent of cases were identified as MSM. Crude incidence rates in MSM, ranging in age between 20 and 44 years, peaked in 2001 at 719 cases per 100000 of the MSM population. A total of 17.4% of cases occurred in HIV-infected individuals. Crude incidence rates of syphilis in HIV-positive MSM in the center increased to 7280 per 100000. Similar percentages of MSM with and without HIV infection had unprotected anal intercourse (37% and 41%, respectively).
CONCLUSION: High-risk sexual behavior continues among HIV-infected and -noninfected MSM. Crude incidence rates among MSM in Ireland are alarming when compared with other outbreaks.

Entities:  

Mesh:

Year:  2004        PMID: 15107636     DOI: 10.1097/01.olq.0000123653.84940.59

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  13 in total

Review 1.  Syphilis: the renaissance of an old disease with oral implications.

Authors:  Giuseppe Ficarra; Roman Carlos
Journal:  Head Neck Pathol       Date:  2009-07-22

Review 2.  Biological basis for syphilis.

Authors:  Rebecca E Lafond; Sheila A Lukehart
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  Syphilis, psychiatry and offending behaviour: clinical cases from nineteenth-century Ireland.

Authors:  B D Kelly
Journal:  Ir J Med Sci       Date:  2008-12-04       Impact factor: 1.568

Review 4.  As through a glass, darkly: the future of sexually transmissible infections among gay, bisexual and other men who have sex with men.

Authors:  Mark Richard Stenger; Stefan Baral; Shauna Stahlman; Dan Wohlfeiler; Jerusha E Barton; Thomas Peterman
Journal:  Sex Health       Date:  2017-02       Impact factor: 2.706

5.  Enhanced molecular typing of treponema pallidum: geographical distribution of strain types and association with neurosyphilis.

Authors:  Christina M Marra; Sharon K Sahi; Lauren C Tantalo; Charmie Godornes; Tara Reid; Frieda Behets; Anne Rompalo; Jeffrey D Klausner; Yue Ping Yin; Fiona Mulcahy; Matthew R Golden; Arturo Centurion-Lara; Sheila A Lukehart
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

6.  Laboratory diagnosis of syphilis with automated immunoassays.

Authors:  Antonella Marangoni; Alessandra Moroni; Silvia Accardo; Roberto Cevenini
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

7.  Reducing sexual risk behaviors and alcohol use among HIV-positive men who have sex with men: a randomized clinical trial.

Authors:  Mary M Velasquez; Kirk von Sternberg; David H Johnson; Charles Green; Joseph P Carbonari; Jeffrey T Parsons
Journal:  J Consult Clin Psychol       Date:  2009-08

8.  Trends in primary and secondary syphilis among men who have sex with men in the United States.

Authors:  James D Heffelfinger; Emmett B Swint; Stuart M Berman; Hillard S Weinstock
Journal:  Am J Public Health       Date:  2007-04-26       Impact factor: 9.308

9.  Evaluation of the BioPlex 2200 syphilis system as a first-line method of reverse-sequence screening for syphilis diagnosis.

Authors:  Antonella Marangoni; Paola Nardini; Claudio Foschi; Alessandra Moroni; Antonietta D'Antuono; Letizia Bacchi Reggiani; Roberto Cevenini
Journal:  Clin Vaccine Immunol       Date:  2013-05-22

10.  Epidemiology of syphilis-related hospitalisations in Spain between 1997 and 2006: a retrospective study.

Authors:  Laura García-García; M Carmen Ariza-Megía; Alba González-Escalada; Alejandro Alvaro-Meca; Angel Gil-Demiguel; Ruth Gil-Prieto
Journal:  BMJ Open       Date:  2011-01-01       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.